Kavuru Vimal's Form 4 filing
Grace Therapeutics, Inc. (GRCE) · filed Sep 27, 2023
- Accession no.
- 0001062993-23-018542
- Filed
- Sep 27, 2023, 7:46 PM ET
- Trade date
- Sep 25, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $1.25M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kavuru VimalCIK 0001697184 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2023 | Common Shares | PPurchaseAcquired | +676,371 | $1.85 | +$1,249,933.61 | 1,188,076 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2023 | Common Shares | PPurchaseAcquired | +422,732 | $0.125 | +$52,841.5 | 422,732 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.